Buy I-Mab Stock | IMAB Stock Price & Latest News | Public.com

I-Mab

$0.00 (0.00%)Today

    About IMAB

    I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Rating

    What Wall St. analysts suggest for this stock

    1

    Price Targets

    What analysts think this stock will be worth

    $29.41
    current
    $17.34
    average

    Events

    List of events that could affect this stock.

    31Mar

    Earnings data Q4 2019

    14Jul

    Earnings data Q2 2020

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.38
    -0.57
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.57

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,63B
    Volume1,22k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$32.89
    1 Year Low$9.30
    Open$29.37
    High$29.42
    Low$28.80

    Buy any stock with any amount of money.

    Download the App
    Download the app